The key question is not which peptide is "better." It is which peptide produces the best outcome for your specific situation, tolerability profile, and research goals
In cells , GLP-1(736) activates the GLP-1 receptor (GLP1R), which increases intracellular cAMP levels and subsequently activates PKA and CREB, leading to enhanced insulin secretion
Conclusion GLP drugs represent a major advancement in the management of obesity and cardiovascular health in addition to the management of type 2 diabetes, for which they were originally developed
It means the drug may be given to people inside authorised clinical trials, and may not be sold or prescribed as a medicine
Type 1 Diabetics: GLP-1 medications are not effective for Type 1 Diabetes
During your consultation, our team will evaluate your health history, goals, and lifestyle to determine if this approach is right for you